Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.3K Buy
1,772
+886
+100% +$50.6K ﹤0.01% 590
2026
Q1
$52.6K Hold
886
﹤0.01% 671
2025
Q4
$34.7K Hold
886
﹤0.01% 762
2025
Q3
$35.8K Buy
+886
New +$36.1K ﹤0.01% 752
2023
Q3
Sell
-700
Closed -$26.6K 1035
2023
Q2
$26.6K Buy
+700
New +$25.3K ﹤0.01% 678

Other funds holding OVV

HM Payson & Co's OVV Position: Q2 2026 in Review

HM Payson & Co increased its Ovintiv (OVV) stake by 100% in Q2 2026, buying an estimated $50.6K and bringing the position to 1,772 shares worth $93.3K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

HM Payson & Co first reported a position in OVV in Q2 2023 and has held it in 5 quarters since. 590 funds tracked by Wall St. Rank hold OVV as of Q2 2026.

  • HM Payson & Co held 1,772 shares of Ovintiv worth $93.3K as of Q2 2026.
  • HM Payson & Co bought 886 Ovintiv shares in Q2 2026, an estimated $50.6K.
  • Ovintiv made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #590 holding.
  • HM Payson & Co first reported a position in Ovintiv in Q2 2023 and has held it in 5 quarters since.
  • 590 funds tracked by Wall St. Rank held Ovintiv as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.